ARID1A and cancer: ARID1A increases the risk for cancer by promoting CYP450 (CYP2E1) transcriptional activation and reactive oxygen species (ROS) production in vivo, while decreasing metastasis via the transcriptional regulation of EMILIN1/MAT1A/LCN2/IL1R1 in vitro [26].